Invibio

Invibio is a leading global provider of implant-grade PEEK (polyetheretherketone) polymers and biomaterial solutions for medical device manufacturers. The company specializes in PEEK-OPTIMA™ polymer formulations designed for long-term implantable medical devices, offering an alternative to traditional metal implants with advantages in biocompatibility, radiolucency, and bone-like mechanical properties. Products are engineered for spinal fusion cages, hip and knee replacements, trauma fixation plates, craniomaxillofacial reconstruction, sports medicine implants, and advanced applications including active implants and drug delivery systems. PEEK-OPTIMA™ materials are ISO 13485:2016 certified and comply with ISO 10993 biocompatibility standards, with FDA 510(k) clearance, CE Mark, and MDR compliance. The material portfolio includes standard grades and HA (hydroxyapatite) enhanced variants supporting osseointegration. Invibio maintains full supply chain control from monomer synthesis to finished polymer, backed by Victrex's manufacturing infrastructure. Clinical track record includes over 20 years of proven performance, approximately 15 million implanted devices worldwide, and zero material-related recalls. Beyond material supply, Invibio provides engineering support, design consultation, regulatory pathway guidance, biocompatibility and mechanical testing resources, and innovation partnership programs to accelerate medical device development timelines and reduce market risk for OEM partners.